Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Neurosci Lett ; 647: 147-152, 2017 04 24.
Article in English | MEDLINE | ID: mdl-28336340

ABSTRACT

Prolactin (PRL) has been shown to be altered by psychotropic drugs, including antidepressant drugs (ADs). Many studies have focused on the response to antidepressant treatment (especially related to the serotonergic system) using the fenfluramine test (PRF), however some data suggest lack of correlation between PRF and prediction of clinical response to ADs. In our study we have investigated the hypothesis that basal plasma level of prolactin is a better predictor of antidepressant treatment. We have used Chronic Mild Stress (CMS) - the animal model of depression. Rats are exposed to CMS in combination with imipramine (IMI) treatment for 5 consecutive weeks. Blood samples were collected from the rat tail vein three times: before the CMS procedure, after 2 weeks of stress and after the complete CMS procedure (after 5 weeks of stress and IMI treatment). The PRL level in plasma was determined using the commercially available ELISA kit. In CMS, anhedonia in rats is manifested by reduced consumption of sucrose solution while administration of antidepressant drugs reverses anhedonia. Some animals (ca.30%) did not respond to antidepressant therapy and were considered treatment-resistant. There was no correlation between basal PRL levels and stress response, however, from the results obtained by Spearman Rank Correlation analysis we have observed a significant negative correlation between basal PRL levels before the CMS procedure and behavioral response to IMI administration. The obtained results indicate that the basal PRL level in rat plasma correlates with a good response to treatment in the animal model of depression.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/drug therapy , Imipramine/therapeutic use , Prolactin/blood , Anhedonia/drug effects , Animals , Depression/blood , Depression/psychology , Male , Rats , Stress, Psychological/blood , Stress, Psychological/drug therapy , Stress, Psychological/psychology , Sucrose/administration & dosage
2.
Psychopharmacology (Berl) ; 233(2): 255-66, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26462807

ABSTRACT

RATIONALE: The involvement of somatostatin (SST) and its receptors in the pathophysiology of depression and stress has been evidenced by numerous studies. OBJECTIVES: The purpose of the present study was to find whether chronic mild stress (CMS), an animal model of depression, affects the SST receptors in the rat brain and pituitary, as well as the level of SST in plasma. METHODS: In CMS model, rats were subjected to 2 weeks of stress and behaviorally characterized using the sucrose consumption test into differently reacting groups based on their response to stress, i.e., stress-reactive (anhedonic), stress-non-reactive (resilient), and invert-reactive rats (characterized by excessive sucrose intake). We measured specific binding of [125I]Tyr3-Octreotide, expression of mRNA encoding sst2R receptors in the rat brains, expression of SST and its receptors in rat pituitary, and the level of SST in the plasma. RESULTS: The obtained results show decreases in binding of [125I]Tyr3-Octreotide in most of rat brain regions upon CMS and no significant differences between three stressed groups of animals, except for significant up-regulation of sst2 receptor in medial habenula (MHb) in the stress-reactive group. In the same group of animals, significant increase in plasma SST level was observed. CONCLUSIONS: There are two particularly sensitive sites distinguishing the response to stress in CMS model. In the brain, it is MHb, while on the periphery this predictor is SST level in plasma. These changes may broaden an understanding of the mechanisms involved in the stress response and point to the intriguing role of MHb.


Subject(s)
Receptors, Interleukin-1/metabolism , Stress, Psychological/psychology , Anhedonia , Animals , Brain Chemistry , Chronic Disease , Gene Expression Regulation/drug effects , Habenula/metabolism , Male , Octreotide/analogs & derivatives , Octreotide/metabolism , Pituitary Gland/metabolism , Rats , Rats, Wistar , Resilience, Psychological/drug effects
3.
Nature ; 440(7082): 315-8, 2006 Mar 16.
Article in English | MEDLINE | ID: mdl-16541068

ABSTRACT

Systems of three interacting particles are notorious for their complex physical behaviour. A landmark theoretical result in few-body quantum physics is Efimov's prediction of a universal set of bound trimer states appearing for three identical bosons with a resonant two-body interaction. Counterintuitively, these states even exist in the absence of a corresponding two-body bound state. Since the formulation of Efimov's problem in the context of nuclear physics 35 years ago, it has attracted great interest in many areas of physics. However, the observation of Efimov quantum states has remained an elusive goal. Here we report the observation of an Efimov resonance in an ultracold gas of caesium atoms. The resonance occurs in the range of large negative two-body scattering lengths, arising from the coupling of three free atoms to an Efimov trimer. Experimentally, we observe its signature as a giant three-body recombination loss when the strength of the two-body interaction is varied. We also detect a minimum in the recombination loss for positive scattering lengths, indicating destructive interference of decay pathways. Our results confirm central theoretical predictions of Efimov physics and represent a starting point with which to explore the universal properties of resonantly interacting few-body systems. While Feshbach resonances have provided the key to control quantum-mechanical interactions on the two-body level, Efimov resonances connect ultracold matter to the world of few-body quantum phenomena.

4.
Pneumonol Alergol Pol ; 61(11-12): 622-5, 1993.
Article in Polish | MEDLINE | ID: mdl-8148763

ABSTRACT

Epidemic intra-ward infection caused by Pneumocystis carinii was described. 18 infants and small children were ill from among 21 treated in the infants ward. The diagnosis was given on the grounds of cytologic examination of bronchial excretion from subglottic region.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , Pneumocystis Infections/epidemiology , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Pneumocystis Infections/diagnosis , Poland/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...